By using bispecific antibodies targeting a tumor-associated antigen (TAA) on the cancer cells, and CD3 on the T-cells, it is possible to redirect and activate any circulating T-cells against tumor cells independently of the specificity of their TCR. Thanks to the bridging action of such TAAxCD3 bsAb, T-cells are brought in close proximity of the target cancer cells, leading to subsequent T-cell activation and T-cell–mediated killing of the tumor cells.
For more information on T-cell redirecting κλ-bodies, please visit Light Chain Bioscience.
Read our latest news
In early November 2020, we invited pharma and biotech companies to tell us how they would use our CX-A in their research, to solve one of the 10 threats to the human population identified by the World Health Organization in 2019. We were inundated by high quality...
Nanolive wants to offer all their friends an original present to start 2021 with the right foot. Choose from 12 very nice live cell imaging backgrounds. Simply select your favorite one and click on “download”. The image will then be fully displayed on your screen -...
Table of content Superparamagnetic iron oxide nanoparticles (SPIONs) are widely used in biomedical applications Could Nanolive’s label-free live cell imaging help? The (highly promising) results References Superparamagnetic iron oxide nanoparticles (SPIONs) are widely...
3D CELL EXPLORER
Budget-friendly, easy-to-use, compact solution for high quality non-invasive 4D live cell imaging
3D CELL EXPLORER-fluo
Multimodal Complete Solution: combine high quality non-invasive 4D live cell imaging with fluorescence